Bauer WM, Fenzl G, Vogl Th, Fink U, Lissner J. Indications for the use of Gd‐DTPA in MRI of the central nervous system: experience in patients with cerebral and spinal diseases. Invest Radiol 1988;23(Suppl 1):S286‐S288. A total of 209 intracranial and spinal diseases were evaluated before and after administration of the paramagnetic contrast agent Gd‐DTPA. The results justify the use of Gd‐DTPA in intracranial and spinal tumors for better visualization of location and extent of a lesion and for better tissue differentiation. In inflammatory diseases Gd‐DTPA allows the differentiation between active and chronic lesions.